Epidemiologic, Virologic, and Host Genetic Factors of Norovirus Outbreaks in Long-term Care Facilities.
暂无分享,去创建一个
J. Vinjé | P. Cieslak | L. Lee | A. Hall | V. Costantini | M. Bierhoff | Emilie M Cooper | Hope L Hardaker | Christianne Biggs
[1] D. Graham,et al. Mucosal and Cellular Immune Responses to Norwalk Virus. , 2015, The Journal of infectious diseases.
[2] P. Szilagyi,et al. Innate Susceptibility to Norovirus Infections Influenced by FUT2 Genotype in a United States Pediatric Population. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] C. Moe,et al. Disease course and viral shedding in experimental Norwalk virus and Snow Mountain virus infection , 2014, Journal of medical virology.
[4] P. Teunis,et al. Shedding of norovirus in symptomatic and asymptomatic infections , 2014, Epidemiology and Infection.
[5] Marion Koopmans,et al. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. , 2014, The Lancet. Infectious diseases.
[6] J. Le Pendu,et al. Increase in genogroup II.4 norovirus host spectrum by CagA-positive Helicobacter pylori infection. , 2014, The Journal of infectious diseases.
[7] Jan Vinjé,et al. Advances in Laboratory Methods for Detection and Typing of Norovirus , 2014, Journal of Clinical Microbiology.
[8] D. Graham,et al. Determination of the 50% human infectious dose for Norwalk virus. , 2014, The Journal of infectious diseases.
[9] Jan Vinjé,et al. Norovirus Disease in the United States , 2013, Emerging infectious diseases.
[10] L. Gould,et al. Acute Gastroenteritis Surveillance through the National Outbreak Reporting System, United States , 2013, Emerging infectious diseases.
[11] J. Vinjé,et al. Effects and Clinical Significance of GII.4 Sydney Norovirus, United States, 2012–2013 , 2013, Emerging infectious diseases.
[12] D. Sano,et al. Histo-Blood Group Antigen-Like Substances of Human Enteric Bacteria as Specific Adsorbents for Human Noroviruses , 2013, Journal of Virology.
[13] J. Vinjé,et al. Emergence of New Norovirus Strain GII.4 Sydney — United States, 2012 , 2013, MMWR. Morbidity and mortality weekly report.
[14] D. Bernstein,et al. Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans. , 2012, The Journal of infectious diseases.
[15] A. Curns,et al. Hospitalizations and mortality associated with norovirus outbreaks in nursing homes, 2009-2010. , 2012, JAMA.
[16] D. Partridge,et al. Lessons from a large norovirus outbreak: impact of viral load, patient age and ward design on duration of symptoms and shedding and likelihood of transmission. , 2012, The Journal of hospital infection.
[17] P. Teunis,et al. Nosocomial transmission of norovirus is mainly caused by symptomatic cases. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] M. Nei,et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. , 2011, Molecular biology and evolution.
[19] J. Vinjé,et al. Impact of an emergent norovirus variant in 2009 on norovirus outbreak activity in the United States. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] J. Vinjé,et al. Novel Surveillance Network for Norovirus Gastroenteritis Outbreaks, United States , 2011, Emerging infectious diseases.
[21] J. Vinjé,et al. Updated norovirus outbreak management and disease prevention guidelines. , 2011, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[22] P. Pothier,et al. Qualitative and Quantitative Analysis of the Binding of GII.4 Norovirus Variants onto Human Blood Group Antigens , 2011, Journal of Virology.
[23] K. Mizuta,et al. Duration of norovirus excretion and the longitudinal course of viral load in norovirus-infected elderly patients. , 2010, The Journal of hospital infection.
[24] J. Vinjé,et al. Epidemiological and genetic characteristics of norovirus outbreaks in long-term care facilities, 2003–2006 , 2010, Epidemiology and Infection.
[25] L. Svensson,et al. Norovirus Gastroenteritis Outbreak with a Secretor-independent Susceptibility Pattern, Sweden , 2010, Emerging infectious diseases.
[26] R. Glass,et al. Molecular Epidemiology of Genogroup II-Genotype 4 Noroviruses in the United States between 1994 and 2006 , 2009, Journal of Clinical Microbiology.
[27] Reem Abu Mallouh,et al. The G428A Nonsense Mutation in FUT2 Provides Strong but Not Absolute Protection against Symptomatic GII.4 Norovirus Infection , 2009, PloS one.
[28] L. Svensson,et al. Genetic susceptibility to symptomatic norovirus infection in Nicaragua , 2009, Journal of medical virology.
[29] D. Graham,et al. Norwalk Virus Shedding after Experimental Human Infection , 2008, Emerging infectious diseases.
[30] P. Teunis,et al. Norwalk virus: How infectious is it? , 2008, Journal of medical virology.
[31] P. White,et al. Norovirus Excretion in an Aged-Care Setting , 2008, Journal of Clinical Microbiology.
[32] W. Leung,et al. Fecal Viral Load and Norovirus-associated Gastroenteritis , 2006, Emerging infectious diseases.
[33] B. Wahrén,et al. A nonsense mutation (428G→A) in the fucosyltransferase FUT2 gene affects the progression of HIV-1 infection , 2006, AIDS.
[34] K. Hedlund,et al. A Homozygous Nonsense Mutation (428G→A) in the Human Secretor (FUT2) Gene Provides Resistance to Symptomatic Norovirus (GGII) Infections , 2005, Journal of Virology.
[35] Xi Jiang,et al. Human susceptibility and resistance to Norwalk virus infection , 2003, Nature Medicine.
[36] R. Baric,et al. Binding of Norwalk Virus-Like Particles to ABH Histo-Blood Group Antigens Is Blocked by Antisera from Infected Human Volunteers or Experimentally Vaccinated Mice , 2002, Journal of Virology.
[37] J. Le Pendu,et al. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals , 2002, Gastroenterology.
[38] William R. Taylor,et al. The rapid generation of mutation data matrices from protein sequences , 1992, Comput. Appl. Biosci..